Shenzhen Stock Exchange: Plans to publicly recognize Yang Zhenghui as unsuitable to serve as a director, supervisor, or senior executive of a listed company for ten years and to impose a public reprimand
Shenzhen Stock Exchange issued a notice of delivery regarding the "Advance Notice of Disciplinary Action": Yang Zhenghui, as a relevant party of Changjiang Pharmaceutical Holdings Co., Ltd., is suspected of violating Article 1.4 of the "Rules for the Listing of Stocks on the Growth Enterprise Market (Revised in August 2023)"; Li Jinfeng, during his tenure as chairman of Changjiang Pharmaceutical Holdings Co., Ltd., is suspected of violating Article 1.4, Article 4.2.2, Item 5 of the first paragraph, and Article 5.1.2 of the "Rules for the Listing of Stocks on the Growth Enterprise Market (Revised in 2023)"
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments